Do These 3 Healthcare Stocks Need a Checkup?
Pfizer has a sizable 6.8% yield and is down nearly 60% from its 2021 highs. Bristol Myers Squibb…
Eli Lilly Trims Price of Popular Weight-Loss Drug on Its Site a Month After Trump Deal
Shelby Knowles / Bloomberg / Getty Images Eli Lilly shares have added over a third of their value…
Lilly cuts price for obesity drug Zepbound
Trump announces lower prices coming for GLP-1 drugs Zepbound, Wegovy President Donald Trump announces discounted pricing for Zepbound…
Seasoned Healthcare Executive Raises $52 Million For An AI Health Startup
Michelle Carnahan has spent the better part of the last three decades working in healthcare at companies like…
Novo cuts Wegovy prices, Zepbound cost also coming down
Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients…
Ozempic Prices Lowered After Trump Deal
Topline Novo Nordisk on Monday lowered the direct-to-consumer prices of its weight loss drug Wegovy and diabetes treatment…
Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare Giants’ Stocks?
Don’t look now, but the costs of America’s beloved weight loss drugs are about to come down. Way…
Eli Lilly, Tan France launch Zepbound ‘Changing the Thread’
New innovative campaign weaves science and storytelling to help reframe obesity as a chronic disease INDIANAPOLIS, Nov. 10,…
Mounjaro mounts to top spot in Indian drug market; Oct sales touch ₹100 cr, ETPharma
New Delhi: Maintaining its growth momentum for the seventh straight month, Eli Lilly’s type-2 diabetes and weight-loss drug…
Mark Cuban Praises TrumpRx Deal With Eli Lilly, Novo Nordisk
When President Trump told an audience in October that he hoped to cut the cost of Ozempic down…